查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750720

免疫組織化學市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2025 年至 2030 年

Immunohistochemistry Market Size, Share & Trends Analysis Report By Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Research), By End use (Hospitals & Diagnostic Laboratories), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

免疫組織化學市場的成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球免疫組織化學市場規模預計到 2030 年將達到 35 億美元，預計 2025 年至 2030 年期間的複合年成長率為 6.93%。

對精準數據的高度需求推動了免疫組化（IHC）技術的多項進步，從而實現了精準且具有上下文相關性的數據分析。多重免疫組化、計算病理學和下一代免疫組化等先進技術的興起正在推動全球市場的發展。免疫組化方案在臨床病理學中越來越受歡迎，尤其是在腫瘤病理學、血液病理學和神經病理學等次專科領域。

這項技術在塑造癌症診斷領域中發揮著至關重要的作用。因此，癌症盛行率的上升預計將增加對免疫組化（IHC）的需求，從而促進市場成長。此外，IHC在藥物研發活動中的廣泛應用預計將在預測期內推動收益成長。全切片成像和數位影像分析可提供高度準確和客觀的評估。因此，影像分析可用於藥物研發的各個方面，例如藥物重新定位、標靶檢驗、患者分層、生物標記表達研究、藥物療效和安全性研究等。

產業參與者意識到該領域帶來的商機，正在持續採取策略性舉措，以提升其市場影響力。例如，2021年6月，PathAI與Astra Zeneca和第一三共株式會社合作，創建了一個基於機器學習的模型，可以自動量化乳癌樣本中的HER2免疫組化影像。全球市場可望受益於已開發國家和新興國家老年人口的成長。隨著全球老年人口的成長，預計與老齡化相關的疾病的盛行率將急劇上升。

免疫組織化學市場亮點

  • 由於在疾病診斷和藥物測試工作流程中進行的免疫組織化學檢測中大量使用抗體，抗體產品領域在 2024 年佔據了市場主導地位。
  • 由於 IHC 測試在診斷環境中的廣泛應用，診斷應用領域在 2024 年引領了市場。
  • 由於製藥公司對新藥研發的投資不斷增加，預計藥物測試領域在預測期內將顯著成長。
  • 醫院和診斷實驗室最終用途部分在 2024 年佔據了最大的收益佔有率。由於 IHC 在藥物發現活動中的應用越來越多，研究機構在預測期內的複合年成長率預計將最快。
  • 由於癌症發病率高、主要參與者的存在以及醫療和生物技術領域的發展等多種因素，預計北美將在 2024 年成為最大的區域市場。
  • 預計亞太地區在預測期內將以最快的複合年成長率成長，其中中國市場成長最為迅速。中國監管核准的不斷增加以及新型免疫組化 (IHC) 解決方案的推出，正在推動中國市場的成長。
  • 主要企業正在努力加強其市場地位並獲得競爭優勢。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章免疫組織化學市場變數、趨勢與範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 免疫組織化學市場分析工具
    • 波特分析
    • PESTEL分析

第4章免疫組織化學市場：按產品的估計和趨勢分析

  • 細分儀表板
  • 免疫組織化學市場：2024 年和 2030 年產品差異分析
  • 抗體
    • 一抗
    • 二抗
  • 裝置
    • 玻片染色系統
    • 組織微陣列
    • 組織處理系統
    • 幻燈片掃描儀
    • 其他
  • 試劑
    • 組織學染色
    • 封閉血清和試劑
    • 呈色受質
    • 固定試劑
    • 穩定劑
    • 有機溶劑
    • 蛋白水解酶
    • 沖淡
  • 套件

第5章免疫組織化學市場：應用評估與趨勢分析

  • 細分儀表板
  • 免疫組織化學市場：2024 年和 2030 年應用趨勢分析
  • 診斷
    • 癌症
    • 感染疾病
    • 心血管疾病
    • 自體免疫疾病
    • 糖尿病
    • 腎臟疾病
  • 調查

第6章免疫組織化學市場：依最終用途的估計和趨勢分析

  • 細分儀表板
  • 免疫組織化學市場：最終用途變異分析，2024 年和 2030 年
  • 醫院和診斷實驗室
  • 研究機構
  • 其他

第7章免疫組織化學市場：按地區估計和趨勢分析

  • 2024 年及 2030 年免疫組織化學市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck KGaA
    • Danaher Corporation
    • PerkinElmer Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • Bio SB
    • Agilent Technologies, Inc.
    • Abcam Limited.
Product Code: GVR-1-68038-718-6

Immunohistochemistry Market Growth & Trends:

The global immunohistochemistry market size is estimated to reach USD 3.50 billion by 2030, registering to grow at a CAGR of 6.93% from 2025 to 2030 according to a new report by Grand View Research, Inc. The high demand for accurate data has driven several technological advancements in IHC techniques, resulting in the delivery of precise and contextual data analyses. The emergence of advanced techniques, such as multiplex IHC, computational pathology, and next-generation IHC, is driving the global market. Immunohistochemistry protocols have gained popularity in clinical pathology, especially in the subspecialties of oncologic pathology, hematopathology, and neuropathology.

The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug discovery and development activities is expected to boost revenue growth over the forecast period. Whole slide imaging and digital image analysis offer highly accurate and objective evaluations. Thus, image analysis can be used across different aspects of drug discovery including drug repositioning, target validation, patient stratification, biomarker expression studies, and drug efficacy & safety studies.

Acknowledging the profitable opportunities posed by the space, operating players in the industry continue to undertake strategic initiatives to strengthen their market presence. For instance, in June 2021, PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd., created machine learning-based models to enable automated quantification of HER2 IHC images in breast cancer samples. The global market will benefit from the growing geriatric population in developed and developing nations. As the global geriatric population increases, the prevalence of age-related illnesses is predicted to rise drastically.

Immunohistochemistry Market Report Highlights:

  • The antibodies product segment led the market in 2024 owing to the high use of antibodies for immunohistochemistry assays carried out for disease diagnosis and drug testing workflows
  • The diagnostics application segment led the market in 2024 owing to the widespread application of IHC tests in diagnostic settings
  • The drug testing segment is expected to witness significant growth during the forecast period. This is due to increasing investment flow by pharmaceutical companies in R&D activities of novel drug discovery and development
  • The hospitals and diagnostic laboratories end-use segment accounted for the largest revenue share in 2024. Research institutes are expected to register the fastest CAGR over the forecast period owing to the increasing adoption of IHC in research institutes for drug discovery activities
  • North America emerged as the largest regional market in 2024 owing to the confluence of multiple factors, such as high cancer prevalence, presence of key players, and developed healthcare & biotechnological sectors
  • The Asia Pacific is projected to grow at the fastest CAGR over the forecast period with China being the fastest-growing market. Increasing regulatory approvals and the launch of novel IHC solutions in China are accelerating the country's market growth
  • Key players are engaged in making focused attempts to reinforce their market position and gain a competitive advantage

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Immunohistochemistry Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Immunohistochemistry Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Immunohistochemistry Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Immunohistochemistry Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Antibodies
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Primary Antibodies
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Secondary Antibodies
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Slide Staining System
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Tissue Microarrays
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Tissue Processing Systems
      • 4.4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Slide Scanners
      • 4.4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Histological stains
      • 4.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Blocking Sera and Reagents
      • 4.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Chromogenic Substrates
      • 4.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Fixation Reagents
      • 4.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Stabilizers
      • 4.5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Organic Solvents
      • 4.5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.8. Proteolytic Enzymes
      • 4.5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.9. Diluents
      • 4.5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Kits
    • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunohistochemistry Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Immunohistochemistry Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Diagnostics
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Cancer
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Infectious Diseases
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Cardiovascular Diseases
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Autoimmune Diseases
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Diabetes Mellitus
      • 5.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Nephrological Diseases
      • 5.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Research
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunohistochemistry Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Immunohistochemistry Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Hospitals & Diagnostic Laboratories
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Research Institutes
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunohistochemistry Market: Regional Estimates & Trend Analysis

  • 7.1. Immunohistochemistry Market Share, By Region, 2024 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Immunohistochemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. F. Hoffmann-La Roche Ltd.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Danaher Corporation
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. PerkinElmer Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bio-Rad Laboratories, Inc.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Cell Signaling Technology, Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Bio SB
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Agilent Technologies, Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Abcam Limited.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global Immunohistochemistry market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global Immunohistochemistry market, by End use, 2018 - 2030 (USD Million)
  • Table 6 North America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 31 France Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 55 China Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 56 China Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 59 India Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 64 South Korea Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 65 South Korea Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA Immunohistochemistry market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 81 MEA Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Immunohistochemistry market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Immunohistochemistry market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Immunohistochemistry market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Immunohistochemistry market: Product outlook key takeaways
  • Fig. 20 Immunohistochemistry market: Product movement analysis
  • Fig. 21 Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Primary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Secondary Antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Slide Staining System market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Tissue Microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Tissue Processing Systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Slide Scanners market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Histological stains market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Blocking Sera and Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Chromogenic Substrates market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Fixation Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Stabilizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Organic Solvents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Proteolytic Enzymes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Diluents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Immunohistochemistry market: Application outlook key takeaways
  • Fig. 41 Immunohistochemistry market: Application movement analysis
  • Fig. 42 Infectious disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Infectious Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Cardiovascular Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Autoimmune Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Diabetes Mellitus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Nephrological Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Immunohistochemistry market: End-use outlook key takeaways
  • Fig. 52 Immunohistochemistry market: End use movement analysis
  • Fig. 53 Hospitals & Diagnostic Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Regional marketplace outlook, 2024 & 2030 (USD million)
  • Fig. 57 Regional marketplace: Key takeaways
  • Fig. 58 North America Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 U.S. Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Canada Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Mexico Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Europe Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 France Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Spain Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Italy Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Denmark Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Norway Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Asia Pacific Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Japan Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 China Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 India Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Australia Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Korea Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Thailand Immunohistochemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Market participant categorization
  • Fig. 97 Immunohistochemistry market position analysis, 2024
  • Fig. 98 Strategic framework